Largest companies by total assets
total assets
| Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $95.64B | Healthcare | Biotechnology | United States | Nasdaq |
| 2 | $49.36B | Healthcare | Biotechnology | United States | Nasdaq |
| 3 | $32.09B | Healthcare | Biotechnology | United States | Nasdaq |
| 4 | $10.96B | Healthcare | Biotechnology | United States | Nasdaq |
| 5 | $5.36B | Healthcare | Biotechnology | United States | Nasdaq |
| 6 | $4.32B | Healthcare | Biotechnology | United States | Nasdaq |
| 7 | $3.14B | Healthcare | Biotechnology | United States | Nasdaq |
| 8 | $2.95B | Healthcare | Biotechnology | United States | Nasdaq |
| 9 | $2.65B | Healthcare | Biotechnology | United States | Nasdaq |
| 10 | $2.59B | Healthcare | Biotechnology | United States | Nasdaq |
| 11 | $2.58B | Healthcare | Biotechnology | United States | Nasdaq |
| 12 | $2.49B | Healthcare | Biotechnology | United States | Nasdaq |
| 13 | $1.65B | Healthcare | Biotechnology | United States | Nasdaq |
| 14 | $1.50B | Healthcare | Biotechnology | United States | Nasdaq |
| 15 | $1.21B | Healthcare | Biotechnology | United States | Nasdaq |
| 16 | $1.21B | Healthcare | Biotechnology | United States | Nasdaq |
| 17 | $1.09B | Healthcare | Biotechnology | United States | Nasdaq |
| 18 | $967.46M | Healthcare | Biotechnology | United States | Nasdaq |
| 19 | $955.58M | Healthcare | Biotechnology | United States | Nasdaq |
| 20 | $915.53M | Healthcare | Biotechnology | United States | Nasdaq |
| 21 | $852.49M | Healthcare | Biotechnology | United States | Nasdaq |
| 22 | $779.57M | Healthcare | Biotechnology | United States | Nasdaq |
| 23 | $691.16M | Healthcare | Biotechnology | United States | Nasdaq |
| 24 | $684.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 25 | $672.44M | Healthcare | Biotechnology | United States | Nasdaq |
| 26 | $640.68M | Healthcare | Biotechnology | United States | Nasdaq |
| 27 | $628.50M | Healthcare | Biotechnology | United States | Nasdaq |
| 28 | $611.14M | Healthcare | Biotechnology | United States | Nasdaq |
| 29 | $557.85M | Healthcare | Biotechnology | United States | Nasdaq |
| 30 | $550.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 31 | $531.63M | Healthcare | Biotechnology | United States | Nasdaq |
| 32 | $523.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 33 | $492.62M | Healthcare | Biotechnology | United States | Nasdaq |
| 34 | $470.43M | Healthcare | Biotechnology | United States | Nasdaq |
| 35 | $467.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 36 | $420.58M | Healthcare | Biotechnology | United States | Nasdaq |
| 37 | $396.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 38 | $386.62M | Healthcare | Biotechnology | United States | Nasdaq |
| 39 | $363.79M | Healthcare | Biotechnology | United States | Nasdaq |
| 40 | $294.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 41 | $292.78M | Healthcare | Biotechnology | United States | Nasdaq |
| 42 | $288.32M | Healthcare | Biotechnology | United States | Nasdaq |
| 43 | $287.01M | Healthcare | Biotechnology | United States | Nasdaq |
| 44 | $260.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 45 | $256.81M | Healthcare | Biotechnology | United States | Nasdaq |
| 46 | $256.73M | Healthcare | Biotechnology | United States | Nasdaq |
| 47 | $254.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 48 | $253.56M | Healthcare | Biotechnology | United States | Nasdaq |
| 49 | $253.06M | Healthcare | Biotechnology | United States | Nasdaq |
| 50 | $252.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 51 | $238.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 52 | $237.36M | Healthcare | Biotechnology | United States | Nasdaq |
| 53 | $236.60M | Healthcare | Biotechnology | United States | Nasdaq |
| 54 | $219.82M | Healthcare | Biotechnology | United States | Nasdaq |
| 55 | $218.88M | Healthcare | Biotechnology | United States | Nasdaq |
| 56 | $213.40M | Healthcare | Biotechnology | United States | Nasdaq |
| 57 | $208.15M | Healthcare | Biotechnology | United States | Nasdaq |
| 58 | $202.85M | Healthcare | Biotechnology | United States | Nasdaq |
| 59 | $197.75M | Healthcare | Biotechnology | United States | Nasdaq |
| 60 | $197.71M | Healthcare | Biotechnology | United States | Nasdaq |
| 61 | $194.46M | Healthcare | Biotechnology | United States | Nasdaq |
| 62 | $191.18M | Healthcare | Biotechnology | United States | Nasdaq |
| 63 | $176.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 64 | $173.70M | Healthcare | Biotechnology | United States | Nasdaq |
| 65 | $171.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 66 | $163.59M | Healthcare | Biotechnology | United States | Nasdaq |
| 67 | $154.22M | Healthcare | Biotechnology | United States | Nasdaq |
| 68 | $142.77M | Healthcare | Biotechnology | United States | Nasdaq |
| 69 | $138.09M | Healthcare | Biotechnology | United States | Nasdaq |
| 70 | $128.35M | Healthcare | Biotechnology | — | Nasdaq |
| 71 | $127.31M | Healthcare | Biotechnology | United States | Nasdaq |
| 72 | $125.92M | Healthcare | Biotechnology | United States | Nasdaq |
| 73 | $125.25M | Healthcare | Biotechnology | United States | Nasdaq |
| 74 | $124.21M | Healthcare | Biotechnology | United States | Nasdaq |
| 75 | $124.00M | Healthcare | Biotechnology | United States | Nasdaq |
| 76 | $120.14M | Healthcare | Biotechnology | United States | Nasdaq |
| 77 | $116.01M | Healthcare | Biotechnology | United States | Nasdaq |
| 78 | $110.34M | Healthcare | Biotechnology | United States | NYSE |
| 79 | $99.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 80 | $93.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 81 | $89.95M | Healthcare | Biotechnology | United States | NYSE |
| 82 | $75.75M | Healthcare | Biotechnology | United States | Nasdaq |
| 83 | $69.83M | Healthcare | Biotechnology | United States | Nasdaq |
| 84 | $66.33M | Healthcare | Biotechnology | United States | Nasdaq |
| 85 | $65.01M | Healthcare | Biotechnology | United States | Nasdaq |
| 86 | $64.52M | Healthcare | Biotechnology | United States | Nasdaq |
| 87 | $63.39M | Healthcare | Biotechnology | USA | Nasdaq |
| 88 | $57.93M | Healthcare | Biotechnology | — | Nasdaq |
| 89 | $56.89M | Healthcare | Biotechnology | United States | Nasdaq |
| 90 | $48.82M | Healthcare | Biotechnology | USA | Nasdaq |
| 91 | $43.65M | Healthcare | Biotechnology | United States | Nasdaq |
| 92 | $37.33M | Healthcare | Biotechnology | United States | Nasdaq |
| 93 | $36.71M | Healthcare | Biotechnology | United States | Nasdaq |
| 94 | $33.29M | Healthcare | Biotechnology | United States | Nasdaq |
| 95 | $33.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 96 | $26.18M | Healthcare | Biotechnology | United States | Nasdaq |
| 97 | $25.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 98 | $24.88M | Healthcare | Biotechnology | United States | Nasdaq |
| 99 | $21.36M | Healthcare | Biotechnology | United States | NYSE |
| 100 | $21.02M | Healthcare | Biotechnology | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 114 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.